Journal of Multiple Sclerosis

Department of Medicine, Menoufia University, Shebeen El-Kom, Egypt

Publications

• Research   
  Outcome of COVID-19 Infection in Multiple Sclerosis (MS) Patients
  Author(s): Rasha Tharwat Mohamed*, Nancy Ali Elqabany, Mona MostafaSaleh Melake and Sabry Elkholy
  
  Objective: To measure the relation between COVID-19 infection and relapse rate in comparison with average Annual Relapse Rate(ARR) in MS patients assessment of infection severity according to line of Disease Modifying Treatment (DMT) in different patients determining the effect of COVID-19 infection on Expanded Disability Status Scale(EDSS). Methods: A prospective multi-center Cohort study was conducted at Menoufia university hospital and Elsheikh Zayed Al Nahyan Hospital on a sample of 200 patient with COVID-19 infection and Multiple Sclerosis(MS) disease during the period from June 2020 to June 2022, it started at the time of visit and for follow up till six-month clinical study after covid-19 infection. Results: There is no significant increase in number of relapses in the 6 months follows up after COVID yet with less.. View More»
  DOI: 10.35248/2376-0389.22.9.10.466

  Abstract HTML PDF